Exploring novel pharmacological approaches to attenuate ischemia reperfusion induced renal injury

dc.contributor.guideThakur Gurjeet Singh and Amarjot Kaur
dc.coverage.spatial
dc.creator.researcherKOMAL THAPA
dc.date.accessioned2024-01-15T11:09:28Z
dc.date.available2024-01-15T11:09:28Z
dc.date.awarded2023
dc.date.completed2023
dc.date.registered2019
dc.description.abstractThe current study explored the pharmacological approaches to reveal the newlinerenoprotective mechanism of Troxerutin, Quinazoline, and PD146176 using novel newlinepharmacological approaches. newlineThe research design involved the introduction of renal ischemia (60 min.) and newlinereperfusion (24 hr.). Troxerutin, Quinazoline, and PD146176 were administered for 10 newlinemin. before renal ischemia for 60 min. and 24hrs of reperfusion to animals separated newlineinto several groups, so that the Pharmacological treatments would be in the systemic newlinecirculation at the time of onset of reperfusion. LY294002 (a specific inhibitor of newlinePhosphatidyl inositol-3 kinase (PI3K), and 666-15 (a specific inhibitor of cAMP newlineresponse element binding protein (CREB) was administered for elucidating the role of newlineseveral signaling pathways modulated by Pharmacological agents. Numerous kidney newlinefunction tests, biochemical markers, and histopathological alterations were evaluated to newlineobserve the outcome of these Pharmacological treatments. It was demonstrated that newlinePharmacological interventions with the above-mentioned agents reduced the destructive newlineeffects of I/R injury as assessed with regard to various kidney function tests (BUN, newlineSCr, Plasma uric acid, and CrCl), biochemical markers of lipid peroxidation and newlineoxidative stress (TBARS, SAG, 15-HETE, SOD and GSH), inflammation (MPO), and newlineinflammatory markers (TNF-and#593;, IL-1and#946;, IL-6, and NF-and#1179;B), apoptotic markers (proapoptotic newlineproteins like Bcl-2 and apoptotic proteins like caspase 3 and Bax), and newlinehistopathological alterations. We conclude that induced renoprotective benefits with newlinePD146176, Troxerutin, and Quinazoline in all probability, may be the consequence of newlineinhibition of the 15-LOX pathway, activation of PI3K pathway and cAMP/CREB newlinepathway and these treatments could be considered, for further research, as probable newlinedrug inducing renoprotection under clinical conditions. newline
dc.description.note
dc.format.accompanyingmaterialDVD
dc.format.dimensions
dc.format.extent
dc.identifier.urihttp://hdl.handle.net/10603/539628
dc.languageEnglish
dc.publisher.institutionFaculty of Pharmacy
dc.publisher.placeChandigarh
dc.publisher.universityChitkara University, Punjab
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordPharmacology and Pharmacy
dc.subject.keywordPharmacology and Toxicology
dc.titleExploring novel pharmacological approaches to attenuate ischemia reperfusion induced renal injury
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 12
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
8.05 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_prelim pages.pdf
Size:
444.83 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_content.pdf
Size:
19.13 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_abstract.pdf
Size:
427.39 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_chapter 1.pdf
Size:
218.64 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: